Pregabalin vs active comparatorsWithdrawals due to adverse events · people with drug‐resistant focal epilepsy1 finding from 1 reviewPregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only1.04 [0.73, 1.48]3 studies · 1286 participantsLow